At Sano, we work with world-leading organisations including University of Cambridge (UK), Genomics England and Imperial College London. We’re dedicated to accelerating the future of personalised medicine so that, one day, anyone can get access to personalised treatments.
Location: United Kingdom, England, Milton
Employees: 11-50
Total raised: $36.84M
Founded date: 2016
Investors 4
| Date | Name | Website |
| 05.03.2022 | Synetro Gr... | synetro.co... |
| - | Cambridge ... | cambridgea... |
| 24.08.2020 | Episode 1 ... | episode1.c... |
| - | Parkwalk A... | parkwalkad... |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 05.02.2024 | - | $11.4M | - |
| 21.12.2022 | Series A | $11M | - |
| 06.04.2022 | Series A | $11M | Episode 1 ... |
| 25.01.2021 | Seed | $3.44M | - |
Mentions in press and media 23
| Date | Title | Description |
| 05.02.2024 | Estonian Plural leads $11.4M round for UK’s Sano Genetics | Estonian Plural leads $11.4M round for UK’s Sano Genetics 05 February, 2024, 10:51 Mariia Denysiuk --> --> --> -->--> --> --> --> --> --> --> --> --> Sano Genetics, a Cambridge-based software platfo... |
| 05.02.2024 | Early-stage UK VC Episode 1 closes $95M third fund | Early stage European venture capital (VC) firm Episode 1 has closed its third fund at £76 million ($95 million), as the London-based investor turns to in-house “data-driven deal sourcing tools” to find the next big thing. Founded in 2013, E... |
| 22.01.2024 | Sano Genetics Secures $11.4M to Turbocharge Precision Medicine Research | What You Should Know: – Sano Genetics, a software company that is revolutionizing precision medicine research, has secured $11.4M in new funding. – This latest investment, led by Plural with participation from existing investors MMC Venture... |
| 22.01.2024 | Exclusive: Sano Genetics nabs $11.4M for precision medicine trials | Sano Genetics, a software platform to facilitate precision medicine-powered clinical trials, raised $11.4 million in funding, CEO Patrick Short tells Axios exclusively. Why it matters: AI can make traditional clinical trials — which are ver... |
| 22.01.2024 | Sano Genetics Raises $11.4M in Funding | Sano Genetics, a Cambridge, UK-based provider of a software platform for precision medicine clinical trials, raised $11.4M in funding. The round, which brought the total amount to $22M, was led by Plural. The company intends to use the fund... |
| 22.01.2024 | Sano Genetics raises $11.4M to advance precision medicine clinical trials | Precision medicine software platform Sano Genetics announced a $11.4 million raise led by Plural today. The only software platform tailored to running precision medicine clinical trials, Sano Genetics leverages AI to manage all aspects, fro... |
| 14.12.2023 | Sano Genetics launches ‘Light the Way’ programme for MND | - |
| 21.03.2023 | Parkwalk – Improving Healthcare by Investing in Genomics | To mark the end of Healthcare Science Week, we discuss the value and impact of investing in genomics. We also give examples of some ground-breaking genomic companies Parkwalk has invested in. |
| 29.03.2022 | Sano Genetics lands $11M Series A | Cambridge-based Sano Genetics has raised $11 million in a round led by MMC Ventures. The startup's platform connects patients who have rare, chronic diseases with researchers conducting personalized studies. The funds will be used for recru... |
| 28.03.2022 | Cambridge startup snags $11 million to fast-track genetic disease research | Cambridge-based Sano Genetics has raised $11 million funding to build patient-friendly tech. The Series A funding round was led by MMC Ventures, with further funding from Episode 1, Seedcamp and several experienced operators in software and... |
Show more